RTC
RPRX icon

Riverview Trust Company’s Royalty Pharma RPRX Stock Holding History

Riverview Trust Company’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,216
Closed -$37.9K – 516
2025
Q1 		$37.9K Hold
1,216
– – 0.04% 265
2024
Q4 		$31K Buy
1,216
+1,186
+3,953% +$31.4K 0.03% 303
2024
Q3 		$849 Buy
+30
New +$831 ﹤0.01% 666
2023
Q1 		– Sell
-527
Closed -$21K – 729
2022
Q4 		$21K Hold
527
– – 0.02% 333
2022
Q3 		$21K Hold
527
– – 0.02% 359
2022
Q2 		$22K Hold
527
– – 0.02% 368
2022
Q1 		$21K Buy
+527
New +$20.7K 0.02% 479

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return